Chapter 119 – Hereditary Spastic Paraplegia

The hereditary spastic paraplegias (HSPs) comprise a large group of inherited neurologic disorders. HSP is classified according to the mode of inheritance, the HSP locus when known, and whether the spastic paraplegia syndrome occurs alone or is accompanied by additional neurologic or systemic abnormalities. Analysis of 11 recently discovered HSP genes provides insight into HSP pathogenesis. Hereditary spastic paraplegia is a clinical diagnosis for which laboratory confirmation is sometimes possible, and careful exclusion of alternate and co-existing disorders is an important element in HSP diagnosis. Treatment for HSP is presently limited to symptomatic reduction of muscle spasticity, reduction in urinary urgency, and strength and gait improvement through physical therapy. Prenatal genetic testing in HSP is possible for some individuals with the increasing availability of HSP gene analysis.

[1]  P. Glynn.  Neural development and neurodegeneration: two faces of Neuropathy Target Esterase , 2000, Progress in Neurobiology.

[2]  J. Kassubek,et al.  Magnetic Resonance Investigation of the Upper Spinal Cord in Pure and Complicated Hereditary Spastic Paraparesis , 2006, European Neurology.

[3]  Y. Sohn,et al.  Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum. , 2004, Parkinsonism & related disorders.

[4]  E. Rugarli,et al.  Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. , 2004, Human molecular genetics.

[5]  K. Gustavson,et al.  Hereditary spastic diplegia with mental retardation in two young siblings , 1989, Clinical genetics.

[6]  Y. Hiss,et al.  Progressive spastic paraparesis, vitiligo, premature graying, and distinct facial appearance: a new genetic syndrome in 3 sibs. , 1981, American journal of medical genetics.

[7]  K. Okamoto,et al.  Vacuole-creating protein in neurodegenerative diseases in humans , 2003, Neuroscience Letters.

[8]  J. Winkler,et al.  Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). , 2004, Archives of neurology.

[9]  Vance Lemmon,et al.  CRASH Syndrome: Clinical Spectrum of Corpus Callosum Hypoplasia, Retardation, Adducted Thumbs, Spastic Paraparesis and Hydrocephalus Due to Mutations in One Single Gene, L1 , 1995, European journal of human genetics : EJHG.

[10]  M. Pericak-Vance,et al.  Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. , 2006, American journal of human genetics.

[11]  D. Lev,et al.  The first nonsense mutation in alsin results in a homogeneous phenotype of infantile‐onset ascending spastic paralysis with bulbar involvement in two siblings , 2003, Clinical genetics.

[12]  J. Haines,et al.  Clinical Heterogeneity of Familial Spastic Paraplegia Linked to Chromosome 2p21 , 1998, Human Heredity.

[13]  J. Gärtner,et al.  Genetic and clinical aspects of X‐linked hydrocephalus (L1 disease): Mutations in the L1CAM gene , 2001, Human mutation.

[14]  J. Hardy,et al.  Variant Alzheimer’s disease with spastic paraparesis , 2000, Neurology.

[15]  M. Pericak-Vance,et al.  Subcellular localization of spastin: implications for the pathogenesis of hereditary spastic paraplegia , 2005, Neurogenetics.

[16]  K. Nave,et al.  Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene , 1992, Nature.

[17]  G. A. Schwarz.  Hereditary (familial) spastic paraplegia. , 1952, A.M.A. archives of neurology and psychiatry.

[18]  Y. Agid,et al.  Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. , 1994, Human molecular genetics.

[19]  L. Ferraiuolo,et al.  Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS , 2007, The Journal of Neuroscience.

[20]  I. Griffiths,et al.  Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene , 2004, Acta Neuropathologica.

[21]  M. Barquero,et al.  Hereditary branchial myoclonus with spastic paraparesis and cerebellar ataxia , 1988, Neurology.

[22]  P. Bergh,et al.  Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome , 2004, Nature Genetics.

[23]  C. Williams,et al.  Prader-Willi and Angelman syndromes: sister imprinted disorders. , 2000, American journal of medical genetics.

[24]  E. Bertini,et al.  Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene , 2004, Neurology.

[25]  R. E. Kalina,et al.  Fleck retina in Kjellin's syndrome. , 1985, American journal of ophthalmology.

[26]  A. Strümpell.  Beiträge zur Pathologie des Rückenmarks , 1880, Archiv für Psychiatrie und Nervenkrankheiten.

[27]  Carsten Konrad,et al.  Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study , 2002, Experimental Brain Research.

[28]  F. Pasquier,et al.  Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. , 2008, Brain : a journal of neurology.

[29]  J. Weissenbach,et al.  Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. , 2000, Human molecular genetics.

[30]  M. Leppert,et al.  Autosomal dominant, familial spastic paraplegia, type I , 1995, Neurology.

[31]  K. Howell,et al.  Role of dynamin in the formation of transport vesicles from the trans-Golgi network. , 1998, Science.

[32]  S. Billings-Gagliardi,et al.  Jimpy-4J mouse has a missense mutation in exon 2 of the Plp gene. , 1997, Developmental neuroscience.

[33]  D. Mellor,et al.  Familial spastic paraplegia, bilateral sensorineural deafness, and intellectual retardation associated with a progressive nephropathy. , 1988, Journal of medical genetics.

[34]  N. Bresolin,et al.  The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. , 2006, Brain : a journal of neurology.

[35]  L. Schöls,et al.  Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia , 2002, Human mutation.

[36]  H. Lohmann,et al.  A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation , 2007, Neurology.

[37]  M. Brin,et al.  Primary lateral sclerosis. A clinical diagnosis reemerges. , 1988, Archives of neurology.

[38]  Jiandong Sun,et al.  Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families , 2005, Human mutation.

[39]  J. Fink,et al.  NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). , 2003, American journal of human genetics.

[40]  K. Broadie,et al.  The Hereditary Spastic Paraplegia Gene, spastin, Regulates Microtubule Stability to Modulate Synaptic Structure and Function , 2004, Current Biology.

[41]  Huili Hu,et al.  A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). , 2008, American journal of human genetics.

[42]  M. Fichera,et al.  Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia , 2004, Neurology.

[43]  Bertrand Fontaine,et al.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia , 1999, Nature Genetics.

[44]  L. Murri,et al.  Motor and somatosensory evoked potentials in Autosomal Dominant Hereditary Spastic Paraparesis (ADHSP) linked to chromosome 2p, SPG4 , 2007, Brain Research Bulletin.

[45]  P. Battistella,et al.  Optic nerve hypoplasia associated with pupillary light-near dissociation, spastic paraparesis and other non-ocular anomalies , 1988, The Italian journal of neurological sciences (Testo stampato).

[46]  G. Holmgren,et al.  Sjögren‐Larsson syndrome in Sweden. A clinical, genetic and epidemiological study , 1981, Clinical genetics.

[47]  S. Kjaergaard,et al.  Prenatal diagnosis of autosomal dominant hereditary spastic paraplegia (SPG4) using direct mutation detection , 2004, Prenatal diagnosis.

[48]  J. Weissenbach,et al.  A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. , 2000, American journal of human genetics.

[49]  M. Pericak-Vance,et al.  A second leaky splice-site mutation in the spastin gene. , 2001, American journal of human genetics.

[50]  A. Gade,et al.  Reduced regional cerebral blood flow in SPG4-linked hereditary spastic paraplegia , 2005, Journal of the Neurological Sciences.

[51]  A. Tessa,et al.  SPG3A: An additional family carrying a new atlastin mutation , 2002, Neurology.

[52]  K. Brockmann,et al.  A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. , 2004, American journal of human genetics.

[53]  W. Rizzo.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. , 2007, Molecular genetics and metabolism.

[54]  D. Kretzschmar,et al.  Swiss Cheese, a Protein Involved in Progressive Neurodegeneration, Acts as a Noncanonical Regulatory Subunit for PKA-C3 , 2008, The Journal of Neuroscience.

[55]  B. Schlotter-Weigel,et al.  Phenotypes of the N88S Berardinelli–Seip congenital lipodystrophy 2 mutation , 2005, Annals of neurology.

[56]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[57]  M. Zatz,et al.  Spastic paraplegia, optic atrophy, and neuropathy is linked to chromosome 11q13 , 2005, Annals of neurology.

[58]  I. Griffiths,et al.  Rumpshaker mouse: A new X-linked mutation affecting myelination: Evidence for a defect in PLP expression , 1990, Journal of neurocytology.

[59]  M. Leppert,et al.  Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q. , 1995, American journal of human genetics.

[60]  K. Kjellin.  Familial spastic paraplegia with amyotrophy, oligophrenia, and central retinal degeneration. , 1959, Archives of neurology.

[61]  G. Wenning,et al.  Olivopontocerebellar atrophy: Toward a better nosological definition , 2006, Movement disorders : official journal of the Movement Disorder Society.

[62]  R. Richardson,et al.  Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen. , 1982, Biochemical pharmacology.

[63]  C. Blackstone,et al.  SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development. , 2006, Human molecular genetics.

[64]  C. Nolte,et al.  Early-onset ALS with long-term survival associated with spastin gene mutation , 2005, Neurology.

[65]  H. Cross,et al.  The Troyer syndrome. A recessive form of spastic paraplegia with distal muscle wasting. , 1967, Archives of neurology.

[66]  P N Leigh,et al.  Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. , 1993, Brain : a journal of neurology.

[67]  G. Gundersen,et al.  Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing , 2005, The Journal of cell biology.

[68]  L. Hudson.  Pelizaeus-Merzbacher Disease and Spastic Paraplegia Type 2 , 2003, Journal of child neurology.

[69]  R. Stevenson,et al.  X–linked spastic paraplegia (SPG1), MASA syndrome and X–linked hydrocephalus result from mutations in the L1 gene , 1994, Nature Genetics.

[70]  A. Reis,et al.  Autosomal dominant spastic paraplegia with anticipation maps to a 4-cM interval on chromosome 2p21-p24 in a large German family , 1996, Human Genetics.

[71]  K. Claeys,et al.  Extending the clinical spectrum of SPG3A mutations to a very severe and very early complicated phenotype , 2008, Journal of Neurology.

[72]  J. Winkler,et al.  Further clinical and genetic characterization of SPG11: hereditary spastic paraplegia with thin corpus callosum. , 2006, Neuropediatrics.

[73]  K. Fenger,et al.  MRI of autosomal dominant pure spastic paraplegia , 1997, Neuroradiology.

[74]  M. Hutchinson,et al.  The prevalence of “pure” autosomal dominant hereditary spastic paraparesis in the island of Ireland , 2002, Journal of neurology, neurosurgery, and psychiatry.

[75]  S. Scherer,et al.  Molecular genetics of X-linked Charcot-Marie-Tooth disease , 2007, NeuroMolecular Medicine.

[76]  I. Griffiths,et al.  The early phenotype associated with the jimpy mutation of the proteolipid protein gene , 1999, Journal of neurocytology.

[77]  M. Simpson,et al.  A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia , 2005, Neurogenetics.

[78]  G. Chenevix-Trench,et al.  Spastic paresis, glaucoma and mental retardation ‐ a probable autosomal recessive syndrome? , 1986, Clinical genetics.

[79]  F. Santorelli,et al.  Hereditary spastic paraplegia caused by the novel mutation 1047insC in the SPG7 gene , 2008, Journal of Neurology.

[80]  A. Nakamura,et al.  Familial spastic paraplegia with mental impairment and thin corpus callosum , 1995, Journal of the Neurological Sciences.

[81]  S. Kenwrick,et al.  Neural cell recognition molecule L1: relating biological complexity to human disease mutations. , 2000, Human molecular genetics.

[82]  J. Hauw,et al.  A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. , 2006, Human molecular genetics.

[83]  F. Lublin,et al.  X-linked pure familial spastic paraparesis. Characterization of a large kindred with magnetic resonance imaging studies. , 1995, Archives of neurology.

[84]  K. Gustavson,et al.  IDENTICAL SYNDROMES OF CEREBRAL PALSY IN THE SAME FAMILY , 1969, Acta paediatrica Scandinavica.

[85]  N. Elleuch,et al.  Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity. , 2008, Archives of neurology.

[86]  P. Hedera,et al.  Mutation in KIF5A can also cause adult-onset hereditary spastic paraplegia , 2006, Neurogenetics.

[87]  W. Schady,et al.  A quantitative study of sensory function in hereditary spastic paraplegia. , 1990, Brain : a journal of neurology.

[88]  P. Shaw,et al.  The microtubule-severing protein Spastin is essential for axon outgrowth in the zebrafish embryo. , 2006, Human molecular genetics.

[89]  L. H. van den Berg,et al.  Spastin mutations in sporadic adult‐onset upper motor neuron syndromes , 2005, Annals of neurology.

[90]  C. Stevens,et al.  Spectrum of X-linked hydrocephalus (HSAS), MASA syndrome, and complicated spastic paraplegia (SPG1): Clinical review with six additional families. , 1995, American journal of medical genetics.

[91]  H. Kurahashi,et al.  Segregation of a pure form of spastic paraplegia and NOR insertion into Xq11.2. , 2000, American journal of medical genetics.

[92]  A. Todorov,et al.  Recessive Familial Spastic Paraplegia with Retinal Degeneration , 1974 .

[93]  M. Feany,et al.  Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine. , 2005, The Journal of clinical investigation.

[94]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.

[95]  P. Steinert,et al.  Sjögren–Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene , 1996, Nature Genetics.

[96]  Timothy A. Miller,et al.  Progressive spinal axonal degeneration and slowness in ALS2‐deficient mice , 2006, Annals of neurology.

[97]  M. Pericak-Vance,et al.  Linkage of a locus for autosomal dominant familial spastic paraplegia to chromosome 2p markers. , 1994, Human molecular genetics.

[98]  A. Terashi,et al.  Neurological and neuroradiological progression in hereditary spastic paraplegia with a thin corpus callosum , 2000, Acta neurologica Scandinavica.

[99]  J. Burnett,et al.  Familial hypobetalipoproteinemia in a Turkish family with hereditary spastic paraplegia. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[100]  S. Brady,et al.  Neuropathology: Many Paths Lead to Hereditary Spastic Paraplegia , 2004, Current Biology.

[101]  M. Armani,et al.  Genetic mapping of a susceptibility locus for disc herniation and spastic paraplegia on 6q23.3-q24.1 , 2002, Journal of medical genetics.

[102]  D. Rubinsztein,et al.  A locus for autosomal dominant "pure" hereditary spastic paraplegia maps to chromosome 19q13. , 2000, American journal of human genetics.

[103]  J. Weissenbach,et al.  Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. , 1998, Journal of medical genetics.

[104]  N. Bresolin,et al.  A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia , 2008, Human mutation.

[105]  M. Spence,et al.  The autosomal dominant form of “pure” familial spastic paraplegia , 1987, Neurology.

[106]  C. Fisher.  Pure Spastic Paralysis of Corticospinal Origin , 1977, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[107]  P. Hedera,et al.  Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia , 2001, Nature Genetics.

[108]  Y. W. Chen,et al.  Large-scale disruption of microtubule pathways in morphologically normal human spastin muscle , 2004, Neurology.

[109]  D. García-Cruz,et al.  Association of late onset spastic paraparesis and dementia: probably an autosomal dominant form of complicated paraplegia. , 1997, American journal of medical genetics.

[110]  C. Hodgkinson,et al.  A novel form of autosomal recessive pure hereditary spastic paraplegia maps to chromosome 13q14 , 2002, Neurology.

[111]  M. Z. Cader,et al.  The role of hereditary spastic paraplegia related genes in multiple sclerosis , 2007, Journal of Neurology.

[112]  J. Stevens,et al.  Familial spastic paraplegia, mental retardation, and precocious puberty. , 1983, Archives of neurology.

[113]  M. Hutchinson,et al.  Linkage of AD HSP and cognitive impairment to chromosome 2p: haplotype and phenotype analysis indicates variable expression and low or delayed penetrance , 1998, European Journal of Human Genetics.

[114]  T. Lerman-Sagie,et al.  Infantile Onset of Hereditary Ascending Spastic Paralysis With Bulbar Involvement , 1996, Journal of child neurology.

[115]  M. Essex,et al.  Nucleotide sequences of human T-lymphotropic virus type I (HTLV-I) from a family cluster with tropical spastic paraparesis/HTLV-I-associated myelopathy. , 1995, Research in virology.

[116]  A. Strümpell.  Die primäre Seitenstrangsklerose (spastische Spinalparalyse) , 1904, Deutsche Zeitschrift für Nervenheilkunde.

[117]  K. Tanaka,et al.  VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration , 2001, Cell Death and Differentiation.

[118]  C. Blackstone,et al.  Cellular Localization, Oligomerization, and Membrane Association of the Hereditary Spastic Paraplegia 3A (SPG3A) Protein Atlastin* , 2003, Journal of Biological Chemistry.

[119]  J. Haines,et al.  Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia. , 2004, Archives of neurology.

[120]  S. Wharton,et al.  The Cellular and Molecular Pathology of the Motor System in Hereditary Spastic Paraparesis due to Mutation of the Spastin Gene , 2003, Journal of neuropathology and experimental neurology.

[121]  A. Cleton-Jansen,et al.  Genomic structure and expression analysis of the spastic paraplegia gene, SPG7 , 1999, Human Genetics.

[122]  M. Dimitrijevic,et al.  A study of posterior column function in familial spastic paraplegia. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[123]  C. Kozak,et al.  Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[124]  G. Demyanenko,et al.  Altered distribution of dopaminergic neurons in the brain of L1 null mice. , 2001, Brain research. Developmental brain research.

[125]  K. Nakayama,et al.  Protrudin Induces Neurite Formation by Directional Membrane Trafficking , 2006, Science.

[126]  P. Glynn,et al.  Membrane Association of and Critical Residues in the Catalytic Domain of Human Neuropathy Target Esterase* , 2000, The Journal of Biological Chemistry.

[127]  D. Boisson,et al.  [Amyotrophic lateral sclerosis occuring befor the age of 40 years. Remarks apropos of 25 cases]. , 1976, Revue neurologique (Paris).

[128]  P. Glynn,et al.  Neuropathy Target Esterase and Its Yeast Homologue Degrade Phosphatidylcholine to Glycerophosphocholine in Living Cells* , 2004, Journal of Biological Chemistry.

[129]  C. Krarup,et al.  Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation , 2004, European journal of neurology.

[130]  M. Johnson,et al.  THE PRIMARY BIOCHEMICAL LESION LEADING TO THE DELAYED NEUROTOXIC EFFECTS OF SOME ORGANOPHOSPHORUS ESTERS , 1974, Journal of neurochemistry.

[131]  Katia J. Evans,et al.  Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[132]  L. Schöls,et al.  Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[133]  M. Devoto,et al.  Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. , 1999, American journal of human genetics.

[134]  M. Mahloudji,et al.  Familial spastic paraplegia with retinal degeneration. , 1968, The Johns Hopkins medical journal.

[135]  M. Pericak-Vance,et al.  A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). , 2002, American journal of human genetics.

[136]  T. Ogura,et al.  The C. elegans homologue of the spastic paraplegia protein, spastin, disassembles microtubules. , 2007, Biochemical and biophysical research communications.

[137]  M. Pericak-Vance,et al.  REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. , 2008, Brain : a journal of neurology.

[138]  N. Bresolin,et al.  SPG11: a consistent clinical phenotype in a family with homozygous Spatacsin truncating mutation , 2007, Neurogenetics.

[139]  W. Seltzer,et al.  Possible Anticipation in Hereditary Spastic Paraplegia Type 4 (SPG4) , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[140]  A. Uitterlinden,et al.  Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation , 2004, The Lancet.

[141]  J. Gomori,et al.  Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. , 2008, American journal of human genetics.

[142]  M. E. Charness,et al.  Alcohol inhibition of cell adhesion in BMP-treated NG108-15 cells. , 1999, Alcoholism, clinical and experimental research.

[143]  O. Combarros,et al.  Hereditary "pure" spastic paraplegia: a study of nine families. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[144]  M. Zatz,et al.  Reevaluation of a large family defines a new locus for X-linked recessive pure spastic paraplegia (SPG34) on chromosome Xq25 , 2008, neurogenetics.

[145]  M. Dogui,et al.  Familial Spastic Paraplegia as the Presenting Manifestation in Patients With Purine Nucleoside Phosphorylase Deficiency , 2003, Journal of child neurology.

[146]  M. Patton,et al.  Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene , 2003, Human mutation.

[147]  J. Weissenbach,et al.  Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q , 1993, Nature genetics.

[148]  H. Weltzien.  Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. , 1979, Biochimica et biophysica acta.

[149]  A. Ludolph,et al.  Cardiomyopathy in motor neuron diseases , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[150]  J. Casida,et al.  Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity , 2003, Nature Genetics.

[151]  P. Hedera,et al.  Infantile onset of hereditary spastic paraplegia poorly predicts the genotype. , 2007, Pediatric neurology.

[152]  L. Santoro,et al.  The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathy , 2005, Journal of Neurology.

[153]  D. Simon,et al.  The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice , 1986, Nature.

[154]  E. Rugarli,et al.  Hereditary spastic paraplegia: clinical genetic study of 15 families. , 2004, Archives of neurology.

[155]  J. M. Sutherland,et al.  Familial spastic paraplegia; its relation to mental and cardiac abnormalities. , 1957, Lancet.

[156]  Jianping Lu,et al.  The hereditary spastic paraplegia protein spartin localises to mitochondria , 2006, Journal of neurochemistry.

[157]  W. Paulus,et al.  ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. , 2006, American journal of human genetics.

[158]  F. Sedel,et al.  Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: A diagnostic approach , 2007, Journal of Inherited Metabolic Disease.

[159]  M. Zatz,et al.  Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. , 2007, American journal of human genetics.

[160]  C. Blackstone,et al.  The Troyer syndrome (SPG20) protein spartin interacts with Eps15. , 2005, Biochemical and biophysical research communications.

[161]  C. Koehler,et al.  Hereditary Spastic Paraplegia: Respiratory Choke or Unactivated Substrate? , 2005, Cell.

[162]  M. Pericak-Vance,et al.  A new locus for dominant hereditary spastic paraplegia maps to chromosome 2p12 , 2006, Neurogenetics.

[163]  C. Sanderson,et al.  The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. , 2005, Human molecular genetics.

[164]  Autosomal dominant familial spastic paraplegia: report of a large New England family , 1990, Clinical genetics.

[165]  E. Hoffman,et al.  Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15 , 1999, Neurology.

[166]  S. Benzer,et al.  The Swiss Cheese Mutant Causes Glial Hyperwrapping and Brain Degeneration in Drosophila , 1997, The Journal of Neuroscience.

[167]  R. Vale,et al.  The Drosophila Homologue of the Hereditary Spastic Paraplegia Protein, Spastin, Severs and Disassembles Microtubules , 2005, Current Biology.

[168]  N. Wood,et al.  Clinical heterogeneity and genotype‐phenotype correlations in hereditary spastic paraplegia because of Spatacsin mutations (SPG11) , 2008, European journal of neurology.

[169]  Erik A Sistermans,et al.  Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. , 2002, Brain : a journal of neurology.

[170]  Hereditary Spastic Paraplegia , 1996, Neurology.

[171]  W. Behan,et al.  Strümpell's familial spastic paraplegia: genetics and neuropathology , 1974, Journal of neurology, neurosurgery, and psychiatry.

[172]  Nick J. Davey,et al.  Estimation of cortical silent period following transcranial magnetic stimulation using a computerised cumulative sum method , 2006, Journal of Neuroscience Methods.

[173]  J. Nielsen,et al.  MEP recruitment curves in multiple sclerosis and hereditary spastic paraplegia , 2005, Journal of the Neurological Sciences.

[174]  N. Bouslam,et al.  Autosomal recessive mutilating sensory neuropathy with spastic paraplegia maps to chromosome 5p15.31–14.1 , 2006, European Journal of Human Genetics.

[175]  N. Murray,et al.  Hereditary motor and sensory neuropathies and hereditary spastic paraplegia: A magnetic stimulation study , 1990, Annals of neurology.

[176]  Peter Nürnberg,et al.  Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. , 2004, American journal of human genetics.

[177]  J. Mcleod,et al.  Electrophysiological studies in familial spastic paraplegia. , 1977, Journal of neurology, neurosurgery, and psychiatry.

[178]  M. Hayden,et al.  Juvenile amyotrophic lateral sclerosis , 2020, Definitions.

[179]  A. Singleton,et al.  SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia , 2008, Neurology.

[180]  D. Louis-bar,et al.  Sur une paraplegic spasmodique avec dégénérescence maculaire chez deux frères , 1945 .

[181]  M. Kostrzewa,et al.  Evidence of a third locus in X-linked recessive spastic paraplegia , 1997, Human Genetics.

[182]  E. Rugarli,et al.  The role of ZFYVE27/protrudin in hereditary spastic paraplegia. , 2008, American journal of human genetics.

[183]  P. S. St George-Hyslop,et al.  Clinical and genetic study of a Brazilian family with spastic paraplegia (SPG6 locus) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[184]  H. Utsumi,et al.  Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15q13–15 , 2000, Annals of neurology.

[185]  E. Bertini,et al.  Infantile ascending hereditary spastic paralysis (IAHSP) , 2003, Neurology.

[186]  J. Burgunder,et al.  Identification of the Drosophila melanogaster homolog of the human spastin gene , 2003, Development Genes and Evolution.

[187]  M. Hayden,et al.  An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred , 2003, Annals of neurology.

[188]  A. Rossi,et al.  Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum , 2004, Neurology.

[189]  V. P. Misra,et al.  Autosomal recessive hereditary sensory neuropathy with spastic paraplegia. , 1994, Brain : a journal of neurology.

[190]  F. Glocker,et al.  Absence of transcallosal inhibition in adolescents with diplegic cerebral palsy , 1999, Muscle & nerve.

[191]  F. Boaretto,et al.  A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28. , 2000, American journal of human genetics.

[192]  L. Guarente,et al.  Proteolipid Protein Is Required for Transport of Sirtuin 2 into CNS Myelin , 2007, The Journal of Neuroscience.

[193]  S. Borrego,et al.  Familial spastic paraplegia with neuropathy and poikiloderma. A new syndrome? , 1992, Clinical genetics.

[194]  D. Vetrie,et al.  Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH. , 1998, American journal of human genetics.

[195]  Y. Agid,et al.  The phenotype of “pure” autosomal dominant spastic paraplegia , 1994, Neurology.

[196]  A. Dürr,et al.  Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. , 2002, American journal of human genetics.

[197]  F. Stanley,et al.  Intrapartum asphyxia: a rare cause of cerebral palsy. , 1988, The Journal of pediatrics.

[198]  G. Gyapay,et al.  Quality assessment of whole genome mapping data in the refined familial spastic paraplegia interval on chromosome 14q. , 1998, Genome research.

[199]  N. Hajjaj-Hassouni,et al.  Spinal cord compression due to vertebral osteochondroma: report of two cases. , 2005, Joint, bone, spine : revue du rhumatisme.

[200]  G. Tedeschi,et al.  Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia , 2002, Annals of neurology.

[201]  D. Troost,et al.  Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[202]  R. Richardson,et al.  SUBCELLULAR DISTRIBUTION OF MARKER ENZYMES AND OF NEUROTOXIC ESTERASE IN ADULT HEN BRAIN 1 , 1979, Journal of neurochemistry.

[203]  C. Konrad.  Brain plasticity and functional reorganization in progressive motor system degeneration , 2006, Journal of the Neurological Sciences.

[204]  A. Strümpell.  Ueber eine bestimmte Form der primären combinirten Systemerkrankung des Rückenmarks , 1886, Archiv für Psychiatrie und Nervenkrankheiten.

[205]  D. Memmos,et al.  Strumpell's Disease in a Family with Hereditary Focal Segmental Glomerulosclerosis , 2006, Renal failure.

[206]  E. Bertini,et al.  Novel locus for autosomal dominant pure hereditary spastic paraplegia (SPG19) maps to chromosome 9q33–q34 , 2002, Annals of neurology.

[207]  H. Hutter,et al.  The C. elegans L1CAM homologue LAD-2 functions as a coreceptor in MAB-20/Sema2–mediated axon guidance , 2008, The Journal of cell biology.

[208]  E. Fransen,et al.  The clinical spectrum of mutations in L1, a neuronal cell adhesion molecule. , 1996, American journal of medical genetics.

[209]  K Fenger,et al.  CAG repeat expansion in autosomal dominant pure spastic paraplegia linked to chromosome 2p21-p24. , 1997, Human molecular genetics.

[210]  M. Schachner,et al.  Disruption of the mouse L1 gene leads to malformations of the nervous system , 1997, Nature Genetics.

[211]  R. M. Stewart,et al.  Familial spastic paraplegia, peroneal neuropathy, and crural hypopigmentation , 1981, Neurology.

[212]  A. Brice,et al.  Spastic paraplegia 15: Linkage and clinical description of three Tunisian families , 2008, Movement disorders : official journal of the Movement Disorder Society.

[213]  J. Opitz,et al.  Familial spastic paraplegia with distal muscle wasting in the Old Order Amish; atypical Troyer syndrome or “new” syndrome * , 1976, Clinical genetics.

[214]  L. Lagae,et al.  Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. , 2000, Neurosurgery.

[215]  E. Bertini,et al.  Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity , 2006, Neurogenetics.

[216]  E. Aronica,et al.  Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes , 2008, Neurology.

[217]  J. Fink.  Progressive Spastic Paraparesis: Hereditary Spastic Paraplegia and Its Relation to Primary and Amyotrophic Lateral Sclerosis , 2001, Seminars in neurology.

[218]  D. Turnbull,et al.  Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England , 2001, Neurology.

[219]  L. Hudson,et al.  Conservative amino acid substitution in the myelin proteolipid protein of jimpymsd mice , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[220]  S. Lidén,et al.  Ichthyosis in the Sjögren‐Larsson syndrome , 1982, Clinical genetics.

[221]  M. Simpson,et al.  Complicated Hereditary Spastic Paraplegia with Thin Corpus Callosum (HSP‐TCC) and Childhood Onset , 2005, Neuropediatrics.

[222]  D. Ito,et al.  [Seipin/BSCL2-related motor neuron disease: Seipinopathy is a novel conformational disease associated with endoplasmic reticulum stress]. , 2007, Rinsho shinkeigaku = Clinical neurology.

[223]  J. Papp,et al.  Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13 , 2001, Nature Genetics.

[224]  H. Stenmark,et al.  Cellular functions of phosphatidylinositol 3-phosphate and FYVE domain proteins. , 2001, The Biochemical journal.

[225]  D. Gambi,et al.  Strümpell's familial spastic paraplegia: an electrophysiological demonstration of selective central distal axonopathy. , 1987, Electroencephalography and clinical neurophysiology.

[226]  A. Durr,et al.  Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases , 2005, Journal of Medical Genetics.

[227]  R. Houlston,et al.  The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. , 2001, American journal of human genetics.

[228]  M. Pericak-Vance,et al.  Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. , 1994, Human molecular genetics.

[229]  H. Coon,et al.  Neuropathy target esterase gene mutations cause motor neuron disease. , 2008, American journal of human genetics.

[230]  N. Bouslam,et al.  Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia , 2005, Journal of Medical Genetics.

[231]  G. Caruso,et al.  Motor and somatosensory evoked potentials in hereditary spastic paraplegia. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[232]  M. Wiedmann,et al.  The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. , 2004, Human molecular genetics.

[233]  J. Fink,et al.  De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. , 2006, Archives of neurology.

[234]  M. Hutchinson,et al.  SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q , 2001, Neurology.

[235]  G. Demyanenko,et al.  Abnormalities in Neuronal Process Extension, Hippocampal Development, and the Ventricular System of L1 Knockout Mice , 1999, The Journal of Neuroscience.

[236]  J. Fink,et al.  Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. , 2005, Archives of neurology.

[237]  C. Chothia,et al.  Outline structure of the human L1 cell adhesion molecule and the sites where mutations cause neurological disorders. , 1996, The EMBO journal.

[238]  S. Lui,et al.  Diffusion tensor imaging of two unrelated Chinese men with hereditary spastic paraplegia associated with thin corpus callosum , 2008, Neuroscience Letters.

[239]  S. Klebe,et al.  Hereditary spastic paraplegia with thin corpus callosum: reduction of the SPG11 interval and evidence for further genetic heterogeneity. , 2006, Archives of neurology.

[240]  K. Claeys,et al.  Hereditary spastic paraplegia 3A associated with axonal neuropathy. , 2007, Archives of neurology.

[241]  M. Strong,et al.  Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: Discrete entities or spectrum? , 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[242]  †Klaus‐Armin Nave,et al.  A Single Nucleotide Difference in the Gene for Myelin Proteolipid Protein Defines the Jimpy Mutation in Mouse , 1987, Journal of neurochemistry.

[243]  Kenji F. Tanaka,et al.  An animal model for late onset chronic demyelination disease caused by failed terminal differentiation of oligodendrocytes. , 2005, Neuron glia biology.

[244]  J. Luzio,et al.  Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. , 2006, Human molecular genetics.

[245]  K. Zinn,et al.  Drosophila Spastin Regulates Synaptic Microtubule Networks and Is Required for Normal Motor Function , 2004, PLoS biology.

[246]  M. Zatz,et al.  A multi-exonic SPG4 duplication underlies sex-dependent penetrance of hereditary spastic paraplegia in a large Brazilian pedigree , 2007, European Journal of Human Genetics.

[247]  P. Glynn,et al.  Loss of Swiss Cheese/Neuropathy Target Esterase Activity Causes Disruption of Phosphatidylcholine Homeostasis and Neuronal and Glial Death in Adult Drosophila , 2005, The Journal of Neuroscience.

[248]  J. Lupski,et al.  Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J , 2007, Nature.

[249]  M Hutchinson,et al.  Age-related cognitive decline in hereditary spastic paraparesis linked to chromosome 2p , 2000, Neurology.

[250]  D. Rubinsztein,et al.  Autosomal dominant spastic paraplegia , 1999, Neurology.

[251]  G. Bernardi,et al.  A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts , 2004, Neurology.

[252]  G. Bernardi,et al.  New locus for hereditary spastic paraplegia maps to chromosome 1p31.1‐1p21.1 , 2005, Annals of neurology.

[253]  K. Nave,et al.  Genetic background determines phenotypic severity of the Plp rumpshaker mutation , 2003, Journal of neuroscience research.

[254]  K. Akassoglou,et al.  Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[255]  O. Combarros,et al.  Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. , 1991, Brain : a journal of neurology.

[256]  R. Marconi,et al.  Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy , 1992, Journal of Neurology.

[257]  L. Rosenbloom,et al.  Familial cerebral palsy associated with normal intelligence. , 1986, Postgraduate medical journal.

[258]  H. Cross,et al.  Troyer syndrome revisited , 2004, Journal of Neurology.

[259]  H. Wootz,et al.  ER stress and neurodegenerative diseases , 2006, Cell Death and Differentiation.

[260]  E. Janus,et al.  Genetic variation in human apolipoprotein E. , 1982, Journal of lipid research.

[261]  K. Nave,et al.  Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.

[262]  C. Blackstone,et al.  Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. , 2006, Pharmacology & therapeutics.

[263]  Greenamyre Jt,et al.  Neurotransmitter receptors in Alzheimer disease. , 1993 .

[264]  B. McCabe,et al.  All neuropathies great and small. , 2005, The Journal of clinical investigation.

[265]  M. Pericak-Vance,et al.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.

[266]  A. Harding.  CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS , 1983, The Lancet.

[267]  T. Nygaard.  Dopa-Responsive Dystonia: Clinical, Pathological, and Genetic Distinction from Juvenile Parkinsonism1 , 1995 .

[268]  P. Courtoy,et al.  Role for dynamin in late endosome dynamics and trafficking of the cation-independent mannose 6-phosphate receptor. , 2000, Molecular biology of the cell.

[269]  R. Stevenson,et al.  Allan-Herndon-Dudley syndrome: clinical and linkage studies on a second family. , 1992, American journal of medical genetics.

[270]  A. Crosby,et al.  SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia , 2003, Journal of the Neurological Sciences.

[271]  E. Reid.  The hereditary spastic paraplegias , 1999, Journal of Neurology.

[272]  C. Broeckhoven,et al.  A novel locus for hereditary spastic paraplegia with thin corpus callosum and epilepsy , 2006, Neurology.

[273]  W. Brown,et al.  Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. , 1992, Brain : a journal of neurology.

[274]  G. Tedeschi,et al.  Multisystem involvement of the central nervous system in Strümpell's disease A neurophysiological and neuropsychological study , 1991, Journal of the Neurological Sciences.

[275]  M. Simpson,et al.  A novel locus for an autosomal recessive hereditary spastic paraplegia (SPG35) maps to 16q21-q23 , 2008, Neurology.

[276]  P. Hedera,et al.  Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia , 2005, Neuroradiology.

[277]  L. V. Bogaert,et al.  Hereditary ataxia with optic atrophy of the retrobulbar neuritis type, and latent pallido-luysian degeneration. , 1949 .

[278]  Imtiaz Qureshi,et al.  Hereditary spastic paraplegia and Evans's syndrome , 1996, Acta paediatrica.

[279]  D. Rubinsztein,et al.  Locus-phenotype correlations in autosomal dominant pure hereditary spastic paraplegia. A clinical and molecular genetic study of 28 United Kingdom families. , 1999, Brain : a journal of neurology.

[280]  J. Cooper,et al.  Human spastin has multiple microtubule‐related functions , 2005, Journal of neurochemistry.

[281]  B. O'neill,et al.  Familial spastic paraplegia with Kallmann's syndrome. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[282]  S. Klebe,et al.  Refinement of the SPG15 candidate interval and phenotypic heterogeneity in three large Arab families , 2007, Neurogenetics.

[283]  A. Durr,et al.  A new phenotype linked to SPG27 and refinement of the critical region on chromosome , 2006, Journal of Neurology.

[284]  L. Qiang,et al.  Microtubules cut and run. , 2005, Trends in cell biology.

[285]  I. Duncan,et al.  Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia , 2004, The Journal of cell biology.

[286]  J. Casida,et al.  Cellular function of neuropathy target esterase in lysophosphatidylcholine action. , 2008, Toxicology and applied pharmacology.

[287]  A. Al-Shubaili,et al.  Hereditary spastic paraparesis with distal muscle wasting, microcephaly, mental retardation, arachnodactyly and tremors: new entity? , 1997, Clinical Neurology and Neurosurgery.

[288]  S. Bundey,et al.  Recurrence Risks in Families of Children with Symmetrical Spasticity , 1977, Developmental medicine and child neurology.

[289]  P. Jennum,et al.  Autosomal dominant pure spastic paraplegia: a clinical, paraclinical, and genetic study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[290]  M. Kruhøffer,et al.  The Hsp60-(p.V98I) Mutation Associated with Hereditary Spastic Paraplegia SPG13 Compromises Chaperonin Function Both in Vitro and in Vivo* , 2008, Journal of Biological Chemistry.

[291]  C. Woods,et al.  A gene for autosomal recessive symmetrical spastic cerebral palsy maps to chromosome 2q24-25. , 1999, American journal of human genetics.

[292]  T. Takayanagi,et al.  The relationship between trinucleotide repeat length and phenotypic variation in Machado-Joseph disease , 1996, Journal of the Neurological Sciences.

[293]  S. Blumen,et al.  A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24‐q32 , 2003, Annals of neurology.

[294]  P. Hedera,et al.  Hereditary Spastic Paraplegia: Genetic Heterogeneity and Genotype-Phenotype Correlation , 1999, Seminars in neurology.

[295]  A. Durr,et al.  Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. , 2008, American journal of human genetics.

[296]  J. Bouchard,et al.  Autosomal dominant primary lateral sclerosis , 2007, Neurology.

[297]  J. Fink,et al.  The hereditary spastic paraplegias: nine genes and counting. , 2003, Archives of neurology.

[298]  J. Winkler,et al.  Long‐term course and mutational spectrum of spatacsin‐linked spastic paraplegia , 2007, Annals of neurology.

[299]  M. Ruberg,et al.  Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. , 2004, Archives of neurology.

[300]  Emmanuel J. Botzolakis,et al.  Hereditary Spastic Paraplegia-Associated Mutations in the NIPA1 Gene and Its Caenorhabditis elegans Homolog Trigger Neural Degeneration In Vitro and In Vivo through a Gain-of-Function Mechanism , 2008, The Journal of Neuroscience.

[301]  L. Rowland.  Primary lateral sclerosis, hereditary spastic paraplegia, and mutations in the alsin gene: Historical background for the first International Conference , 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[302]  W. Trojaborg,et al.  Visual, auditory and somatosensory pathway involvement in hereditary cerebellar ataxia, Friedreich's ataxia and familial spastic paraplegia. , 1981, Electroencephalography and clinical neurophysiology.

[303]  R I Richards,et al.  CAG repeat expansion in autosomal dominant familial spastic paraparesis: novel expansion in a subset of patients. , 1998, Human molecular genetics.

[304]  M. Simpson,et al.  A new locus for autosomal recessive complicated hereditary spastic paraplegia (SPG26) maps to chromosome 12p11.1–12q14 , 2005, Journal of Medical Genetics.

[305]  G. Moretto,et al.  Familial spastic paraplegia with peroneal amyotrophy. A family with hypersensitivity to pyrexia , 1990, The Italian Journal of Neurological Sciences.

[306]  Confirmation of locus heterogeneity in the pure form of familial spastic paraplegia. , 1995, American journal of medical genetics.

[307]  M. Ruberg,et al.  Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum , 2007, Nature Genetics.

[308]  D. Yanase,et al.  Hereditary spastic paraplegia with frontal lobe dysfunction , 2004, Neurology.

[309]  R. Guillery,et al.  Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1 , 1998, Current Biology.

[310]  J. Masdeu,et al.  SPG11 compound mutations in spastic paraparesis with thin corpus callosum , 2008, Neurology.

[311]  B. Tang,et al.  Clinical features of hereditary spastic paraplegia with thin corpus callosum: report of 5 Chinese cases. , 2004, Chinese medical journal.

[312]  O. Paulson,et al.  Motor activation in SPG4-linked hereditary spastic paraplegia , 2006, Journal of the Neurological Sciences.

[313]  M. Passos-Bueno,et al.  Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter , 2005, Journal of Medical Genetics.

[314]  F. Stanley.  The aetiology of cerebral palsy. , 1994, Early human development.

[315]  R. Stevenson,et al.  Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. , 2005, American journal of human genetics.

[316]  E. Rugarli,et al.  Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. , 2004, The Journal of clinical investigation.

[317]  H. Willard,et al.  Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. , 1985, Science.

[318]  J. Fink.  Sporadically occurring neurologic disease , 2008, Neurology.

[319]  C. Blackstone,et al.  Atlastin GTPases are required for Golgi apparatus and ER morphogenesis. , 2008, Human molecular genetics.

[320]  G. Rouleau,et al.  A novel locus for pure recessive hereditary spastic paraplegia maps to 10q22.1‐10q24.1 , 2004, Annals of neurology.

[321]  Y. Hashizume,et al.  Autopsy case of hereditary spastic paraplegia with thin corpus callosum showing severe gliosis in the cerebral white matter , 2005, Neuropathology (Kyoto. 1993).

[322]  D. Ito,et al.  Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17 , 2008, Neurobiology of Disease.

[323]  M. Leppert,et al.  Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8q. , 1999, American journal of human genetics.

[324]  Andrew H Crosby,et al.  Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. , 2008, American journal of human genetics.

[325]  U Walter,et al.  Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). , 2006, Brain : a journal of neurology.

[326]  Shin J. Oh,et al.  Mutant dynactin in motor neuron disease , 2003, Nature Genetics.

[327]  M. Lorrain,et al.  Contribution à l'étude de la paraplégie spasmodique familiale , 1898 .

[328]  Guy Cheron,et al.  Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis , 2000, Neuroscience Letters.

[329]  M Hutchinson,et al.  Autosomal dominant hereditary spastic paraparesis with cognitive loss linked to chromosome 2p. , 1998, Brain : a journal of neurology.

[330]  J. Brody,et al.  Neurofibrillary degeneration on Guam: frequency in Chamorros and non Chamorros with no known neurological disease. , 1979, Brain : a journal of neurology.

[331]  M. Pericak-Vance,et al.  Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. , 2001, American journal of human genetics.

[332]  H. Moser,et al.  X‐linked adrenoleukodystrophy presenting as neurologically pure familial spastic paraparesis , 1995, Neurology.

[333]  F. Andermann,et al.  Striking intrafamilial phenotypic variability and spastic paraplegia in the presence of similar homozygous expansions of the FRDA1 gene , 2004, Movement disorders : official journal of the Movement Disorder Society.

[334]  A. Ballabio,et al.  A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. , 1998, American journal of human genetics.

[335]  L. Ming.  [SPG3A-hereditary spastin paraplegia with genetic anticipation and incomplete penetrance]. , 2007, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[336]  W. Stoffel,et al.  Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: Myelination and development , 2002, Glia.

[337]  P. Bork,et al.  SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia , 2002, Nature Genetics.

[338]  W. Steers,et al.  Intrathecal baclofen in hereditary spastic paraparesis. , 1992, Archives of physical medicine and rehabilitation.

[339]  S. Dimauro,et al.  Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q , 1999, Neurology.

[340]  M. Hallett,et al.  Dystonia with marked diurnal variation associated with biopterin deficiency , 1988, Neurology.

[341]  Christopher J McDermott,et al.  Hereditary spastic paraparesis: Disrupted intracellular transport associated with spastin mutation , 2003, Annals of neurology.

[342]  G. Bernardi,et al.  Silver syndrome variant of hereditary spastic paraplegia , 2008, Neurology.

[343]  N. Hirokawa,et al.  Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.

[344]  K. Hoffmann,et al.  Spastin related hereditary spastic paraplegia with dysplastic corpus callosum , 2005, Journal of the Neurological Sciences.

[345]  D. Rubinsztein,et al.  Subclinical cognitive impairment in autosomal dominant “pure” hereditary spastic paraplegia , 1999, Journal of medical genetics.

[346]  A. Ballabio,et al.  Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia , 2003, The Journal of cell biology.

[347]  A. Matus,et al.  Molecular Cloning of Microtubule‐Associated Protein 1 (MAP1A) and Microtubule‐Associated Protein 5 (MAP1B): Identification of Distinct Genes and Their Differential Expression in Developing Brain , 1990, Journal of neurochemistry.

[348]  P. Hedera,et al.  Prenatal diagnosis of hereditary spastic paraplegia , 2001, Prenatal diagnosis.

[349]  Ronald D. Vale,et al.  Structural basis of microtubule severing by the hereditary spastic paraplegia protein spastin , 2008, Nature.

[350]  E. Rugarli,et al.  Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. , 2002, Human molecular genetics.

[351]  M. Hutchinson,et al.  Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia , 2004, Neurology.

[352]  W. Erb.  Concerning Spastic and Syphilitic Spinal Paralysis * , 1902, British medical journal.

[353]  T. Iwaki,et al.  Autopsy case of autosomal recessive hereditary spastic paraplegia with reference to the muscular pathology , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.

[354]  A. Durr,et al.  Mental deficiency in three families with SPG4 spastic paraplegia , 2008, European Journal of Human Genetics.

[355]  C. Beetz,et al.  Isoform‐specific increase of spastin stability by N‐terminal missense variants including intragenic modifiers of SPG4 hereditary spastic paraplegia , 2007, European journal of neurology.

[356]  S. Hanein,et al.  A novel locus for autosomal dominant “uncomplicated” hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3 , 2007, Human Genetics.

[357]  P. Tonali,et al.  Natural history of young-adult amyotrophic lateral sclerosis , 2008, Neurology.

[358]  E. Rugarli,et al.  The m-AAA Protease Defective in Hereditary Spastic Paraplegia Controls Ribosome Assembly in Mitochondria , 2005, Cell.

[359]  C. Gellera,et al.  Spinocerebellar ataxia type 28: A novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis , 2008, The Cerebellum.

[360]  J. Weissenbach,et al.  Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. , 1996, Brain : a journal of neurology.

[361]  L. Santoro,et al.  Autosomal dominant hereditary spastic paraplegia: DHPLC‐based mutation analysis of SPG4 reveals eleven novel mutations , 2005, Human mutation.

[362]  Xinnan Wang,et al.  Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules , 2007, Nature Neuroscience.

[363]  E. Rugarli,et al.  Spastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus. , 2005, Experimental cell research.

[364]  M. Beal,et al.  The Role of Mitochondria in the Pathogenesis of Neurodegenerative Diseases , 2000, Brain pathology.

[365]  J. Bodensteiner,et al.  Childhood-Onset Spastic Paraplegia With NIPA1 Gene Mutation , 2006, Journal of child neurology.

[366]  F. Micheli,et al.  Hereditary spastic paraplegia associated with dopa‐responsive parkinsonism , 2006, Movement disorders : official journal of the Movement Disorder Society.

[367]  A. Riecker,et al.  Brain atrophy in pure and complicated hereditary spastic paraparesis: a quantitative 3D MRI study , 2006, European journal of neurology.

[368]  M. Pericak-Vance,et al.  Familial spastic paraparesis: evaluation of locus heterogeneity, anticipation, and haplotype mapping of the SPG4 locus on the short arm of chromosome 2. , 1997, American journal of medical genetics.

[369]  D. Barker,et al.  Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia , 1996, Neurology.

[370]  H. Moser,et al.  Familial spastic paraparesis , 1985, Neurology.

[371]  M. Simpson,et al.  Endogenous spartin, mutated in hereditary spastic paraplegia, has a complex subcellular localization suggesting diverse roles in neurons. , 2006, Experimental cell research.

[372]  A. Munnich,et al.  X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus , 1994, Nature Genetics.

[373]  P. Glynn,et al.  Neuropathy target esterase. , 1999, The Biochemical journal.

[374]  M. Mochizuki,et al.  Familial clustering of human T lymphotropic virus type 1 uveitis. , 1993, The British journal of ophthalmology.

[375]  D. Rubinsztein,et al.  A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic heterogeneity. , 1999, American journal of human genetics.

[376]  A. Schapira,et al.  A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia , 2003, Neurology.

[377]  M. Esiri,et al.  The extent of axonal loss in the long tracts in hereditary spastic paraplegia , 2004, Neuropathology and applied neurobiology.

[378]  J. Kassubek,et al.  Restless Legs Syndrome in Hereditary Spastic Paraparesis , 2006, European Neurology.

[379]  J. Statland,et al.  Primary lateral sclerosis , 2007, Muscle & nerve.

[380]  J. Hardy,et al.  Two novel (M233T and ρ278T) presenilin‐1 mutations in early‐onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin‐1 mutations with a novel phenotype , 1997, Neuroreport.

[381]  J. Fink,et al.  CHAPTER L2 – Hereditary Spastic Paraplegia: Clinical Features and Animal Models , 2005 .

[382]  G. Tredici,et al.  Peripheral nerve involvement in familial spastic paraplegia. , 1979, Archives of neurology.

[383]  F. Boaretto,et al.  Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation , 2003, Neurology.

[384]  W. Schady,et al.  Central motor conduction studies in hereditary spastic paraplegia. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[385]  G. Hu,et al.  A novel GTP‐binding protein hGBP3 interacts with NIK/HGK , 2002, FEBS letters.

[386]  Seungbok Lee,et al.  Loss of spastic paraplegia gene atlastin induces age-dependent death of dopaminergic neurons in Drosophila , 2008, Neurobiology of Aging.

[387]  J. Kassubek,et al.  Complicated hereditary spastic paraplegia with thin corpus callosum: Variation of phenotypic expression over time , 2004, Journal of Neurology.

[388]  H. Cross,et al.  Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. , 2003, American journal of human genetics.

[389]  Xinran Liu,et al.  Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A , 2003, The Journal of cell biology.

[390]  M. Pericak-Vance,et al.  Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations , 2004, Neurogenetics.

[391]  E. Hoffman,et al.  The rumpshaker mutation in spastic paraplegia , 1994, Nature Genetics.

[392]  Rebecca Schüle,et al.  Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. , 2008, Human molecular genetics.

[393]  P. Gasparini,et al.  Narrowing of the critical region in autosomal recessive spastic paraplegia linked to the SPG5 locus , 2004, Neuromuscular Disorders.

[394]  A. Durr,et al.  Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13) , 2008, Neuroscience.

[395]  S. Klebe,et al.  Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28) , 2005, Annals of neurology.

[396]  Harding Ae.  Hereditary Spastic Paraplegias , 1993, Seminars in neurology.

[397]  R. Zaizov,et al.  Partial splenectomy in Gaucher's disease. , 1986, Journal of pediatric surgery.

[398]  J. Kassubek,et al.  Cognitive performance in pure and complicated hereditary spastic paraparesis: a neuropsychological and neuroimaging study , 2007, Neuroscience Letters.

[399]  O. Boespflug-Tanguy,et al.  Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis , 2006, Annals of neurology.

[400]  B. Crain,et al.  Autosomal dominant juvenile amyotrophic lateral sclerosis. , 1999, Brain : a journal of neurology.

[401]  J. Jankovic,et al.  Familial spastic paraparesis and deafness. A new x-linked neurodegenerative disorder. , 1986, Archives of neurology.

[402]  K. Fischbeck,et al.  Complicated hereditary spastic paraparesis with cerebral white matter lesions. , 1990, American journal of medical genetics.

[403]  M. Hodes,et al.  Different mutations in the same codon of the proteolipid protein gene, PLP, may help in correlating genotype with phenotype in Pelizaeus-Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2). , 1999, American journal of medical genetics.

[404]  S. Mansour,et al.  Prenatal diagnosis in a family with X‐linked hydrocephalus , 2005, Prenatal diagnosis.

[405]  J. Fryns,et al.  X linked complicated spastic paraplegia, MASA syndrome, and X linked hydrocephalus owing to congenital stenosis of the aqueduct of Sylvius: variable expression of the same mutation at Xq28. , 1991, Journal of medical genetics.

[406]  R. Galvin,et al.  Hereditary sensory neuropathy with spastic paraplegia. , 1979, Brain : a journal of neurology.

[407]  F. McNally,et al.  Two domains of p80 katanin regulate microtubule severing and spindle pole targeting by p60 katanin. , 2000, Journal of cell science.

[408]  G. A. Schwarz,et al.  Hereditary (familial) spastic paraplegia; further clinical and pathologic observations. , 1956, A.M.A. archives of neurology and psychiatry.

[409]  A. Crosby,et al.  Is the transportation highway the right road for hereditary spastic paraplegia? , 2002, American journal of human genetics.

[410]  M. Abou‐Donia.  Organophosphorus ester-induced delayed neurotoxicity. , 1981, Annual review of pharmacology and toxicology.